Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TP53TG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
TPP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ITPR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TTL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NCOA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STX3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBMS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101927144 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ID3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAGED2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPS18B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STK10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HADHB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NIFK-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR6849 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on